关注
Ilgın Kımız Geboloğlu
Ilgın Kımız Geboloğlu
在 ogrenci.ege.edu.tr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Monoclonal antibodies in cancer immunotherapy
I Kimiz-Gebologlu, S Gulce-Iz, C Biray-Avci
Molecular biology reports 45 (6), 2935-2940, 2018
2192018
Exosomes: Large-scale production, isolation, drug loading efficiency, and biodistribution and uptake
I Kimiz-Gebologlu, SS Oncel
Journal of Controlled Release 347, 533-543, 2022
2112022
A bilayer scaffold prepared from collagen and carboxymethyl cellulose for skin tissue engineering applications
C Kilic Bektas, I Kimiz, A Sendemir, V Hasirci, N Hasirci
Journal of Biomaterials Science, Polymer Edition 29 (14), 1764-1784, 2018
432018
Screening of antioxidant and cytotoxic activities of several microalgal extracts with pharmaceutical potential
C Gürlek, Ç Yarkent, A Köse, B Tuğcu, I Kımız-Geboloğlu, SŞ Öncel, ...
Health and Technology 10, 111-117, 2020
332020
Delivery of pemetrexed by magnetic nanoparticles: design, characterization, in vitro and in vivo assessment
G Ak, D Aksu, E Çapkın, Ö Sarı, I Kımız Geboloğlu, ŞH Şanlıer
Preparative Biochemistry & Biotechnology 50 (3), 215-225, 2020
132020
The use of Toxoplasma gondii tachyzoites produced in HeLa cells adhered to Cytodex 1 microcarriers as antigen in serological assays: an application of …
P Sağlam Metiner, H Can, D Ayyıldız Tamiş, M Karakavuk, ...
Cytotechnology 71, 91-105, 2019
102019
Influenza vaccine: an engineering vision from virological importance to production
SF Demirden, K Alptekin, I Kimiz-Gebologlu, SS Oncel
Biotechnology and Bioprocess Engineering 27 (5), 740-764, 2022
62022
Development of a serum free medium for HUMIRA® biosimilar by design of experiment approaches
I Kimiz-Gebologlu, P Saglam-Metiner, O Ozaslan, D Ayyildiz-Tamis, ...
Turkish Journal of Biochemistry 45 (3), 283-294, 2020
62020
Polyclonal Antibody Production Against Hapten Structured KDN Molecule by Using Different Adjuvants Alternative to Freund’s Adjuvant
SG İz, PS Metiner, Ç Kayalı, SİD Gürhan
European Journal of Therapeutics 24 (2), 106-111, 2018
52018
A study of the THP‐1 cell line as the potential biologics production platform with the emphasis on serum‐free media substitution for economic expediency
I Kimiz‐Gebologlu, SF Demirden, SS Oncel
Biotechnology Journal 17 (9), 2200154, 2022
32022
New developments in supercritical fluids as a green technology: Processing of β-glucanase with sub-and supercritical carbon dioxide
D Senyay-Oncel, I Kimiz-Gebologlu, O Yesil-Celiktas
Biochemical Engineering Journal 195, 108934, 2023
22023
Dünden Bugüne Türkiye’de Aşılama ve Aşı Üretiminin Tarihçesi
SF Demirden, K Alptekin, IK Geboloğlu, SŞ Öncel
Türk Mikrobiyoloji Cemiyeti Dergisi, 247, 2022
12022
Animal Cell Lines as Expression Platforms in Viral Vaccine Production: A Post Covid-19 Perspective
SF Demirden, I Kimiz-Gebologlu, SS Oncel
ACS omega 9 (15), 16904-16926, 2024
2024
Importance of Intellectual Property Rights for Building a Sustainable Future
SF Demirden, I Kimiz-Gebologlu, K Alptekin, D Senyay-Oncel
A Sustainable Green Future: Perspectives on Energy, Economy, Industry …, 2023
2023
ICABB 2018
SI Deliloglu-Gurhan, P Saglam-Metiner, I Kimiz-Gebologlu, S Gulce-Iz
2018
Oral Presentation-9
P Saglam-Metiner, I Kimiz-Gebologlu, SS Oncel, O Yesil-Celiktas
History of vaccination and vaccine production in Türkiye: From past to present
SF Demirden, K Alptekin, IK Geboloğlu, SŞ Öncel
系统目前无法执行此操作,请稍后再试。
文章 1–17